InvestorsHub Logo

dream_maker

07/19/18 2:35 PM

#8287 RE: TheLastOneSitting #8286

Thanks for sharing your thoughts. Additionally, Has anyone thought how difficult it maybe to break the pharmaceutical cartel that control this market of test strips that must be purchased which must make them a steady flow of cash?

GrandeS

07/20/18 9:56 AM

#8289 RE: TheLastOneSitting #8286

Definitely not a competitor. Actually this company and all blood glucose test and data companies would want to contract with ALRT to integrate with the ALRT platform. I think this is partly why we are not seeing any new stock buyers. Most people don't understand that ALRT is a platform that accumulates the data for providers and insurers and allows for remote care plan decision making guidance on medications, on patient adherence, on insulin guidance, A1c prediction, etc. Allowing for remote management of large scale populations and allowing for those with diabetes to be placed on the proper care plan is key to improving outcome and reducing cost.